Last C$0.02 CAD
Change Today +0.01 / 100.00%
Volume 617.0K
GES On Other Exchanges
Symbol
Exchange
Venture
Frankfurt
As of 10:49 AM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

gemoscan canada inc (GES) Snapshot

Open
C$0.02
Previous Close
C$0.01
Day High
C$0.02
Day Low
C$0.02
52 Week High
04/2/14 - C$0.10
52 Week Low
01/15/15 - C$0.0050
Market Cap
759.7K
Average Volume 10 Days
254.6K
EPS TTM
C$-0.03
Shares Outstanding
38.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for GEMOSCAN CANADA INC (GES)

Related News

No related news articles were found.

gemoscan canada inc (GES) Related Businessweek News

No Related Businessweek News Found

gemoscan canada inc (GES) Details

Gemoscan Canada, Inc. develops, owns, and markets food sensitivity and dietary management solutions for consumers in Canada. Its solutions include HEMOCODE food intolerance system, a personalized naturopathic nutritional program that promotes well-being. This system also provides personalized dietary guidelines and replacement food suggestions. The company commercializes its food intolerance management solution directly to consumers in partnership with retailers. It has strategic alliance with A.C. Simmonds and Sons. Gemoscan Canada, Inc. was founded in 2003 and is headquartered in Toronto, Canada.

Founded in 2003

gemoscan canada inc (GES) Top Compensated Officers

Chief Executive Officer, President, Director ...
Total Annual Compensation: C$211.3K
Chief Financial Officer and Secretary
Total Annual Compensation: C$56.0K
Compensation as of Fiscal Year 2014.

gemoscan canada inc (GES) Key Developments

Gemoscan Canada, Inc. Forms Strategic Alliance with A.C. Simmonds and Sons

Gemoscan Canada, Inc. announced that it has formed a strategic alliance with A.C. Simmonds and Sons. The Alliance will focus on corporate and business development initiatives focused around Gemoscan's previously stated goals of leveraging its patented intellectual property and proprietary processes to become one of the integrated platforms in the rapidly growing multi-billion dollar North American consumer based healthcare market. The Alliance will help the Company to further expand its position in the health and wellness industry, with a particular focus on natural remedies and treatments.

Gemoscan Canada Seeks Acquisitions

Gemoscan Canada, Inc. (TSXV:GES), which is creating alliance with A.C. Simmonds and Sons Inc. (OTCBB:ACSX), is looking for acquisitions. The company indicated that among other considerations, the alliance will seek to identify and sufficiently capitalize Gemoscan in order to acquire businesses and enter into strategic partnerships that may represent immediately accretive sales while functioning as organic channels for Gemoscan's patented medically supervised diet-related wellness programs in Canada and the United States.

Gemoscan Canada, Inc. Announces Establishment of Wholly Owned Subsidiary, Hemocode USA, Inc

Gemoscan Canada, Inc. announced that it has established a wholly owned subsidiary, Hemocode USA, Inc., through which to sell and market its HemocodeTM and other leading food sensitivity management programs. HUI has been set up under the laws of the state of Delaware. The HemocodeTM System, like the company's other programs, is a personalized medically supervised nutritional program that promotes dietary well being. It uses portions of Gemoscan's patented technology, and proprietary services to provide consultation and recommendations intended to simplify the management of food sensitivities.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GES:CN C$0.02 CAD +0.01

GES Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for GES.
View Industry Companies
 

Industry Analysis

GES

Industry Average

Valuation GES Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.2x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GEMOSCAN CANADA INC, please visit www.hemocode.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.